Patients with stage I or II breast cancer had 4-fold increases in risk of death if they had the T/T genotype compared with C/C (P=0.002) or 2-fold increases in risk of death if they had high compared with low TGF-β1 (P=0.030). Here, TGFB1 is linked to breast cancer.